Rob Sahr on the Administration’s Aggressive Approach to Bayh-Dole Compliance
The Briefing: The Patent Puzzle: USPTO's Guidelines for AI Inventions
The Briefing: The Patent Puzzle: USPTO's Guidelines for AI Inventions (Podcast)
#WorkforceWednesday: Invention Ownership - Why the Tense Matters in Employee IP Provisions - Employment Law This Week® - Spilling Secrets Podcast
Patent Dual-application Strategy in China
How to Write a Technical Disclosure for Patent Drafting
The Utility Model System in China
Williams Mullen Manufacturing Edge: IP Considerations for Manufacturers
Risk Prevention Strategies: Ownership of Employee-Developed Inventions and Intellectual Property
Nonpublication Requests For Patent Applications Part 3: Pitfalls
Healthcare Tech: How Are Licensing Agreements Bridging the Industry Divide?
What Is a Patent and How Do I Get One
Nonpublication Requests For Patent Applications Part 1: Benefits
Monthly Minute | Commercialization of an Invention
[IP Hot Topics Podcast] Innovation Conversations: Walter Isaacson, Part 2
PODCAST: Williams Mullen's Trending Now: An IP Podcast - Patent Searching
PODCAST: Trending Now An IP Podcast - Patent Office Secrecy Orders
IP Monthly Minute | February 2020
JONES DAY TALKS®: When AI Invents: Two Applications Test U.S. Patent Law
6 Key Takeaways | Considerations Before Relying on AIA Prior User Rights
In University of South Florida Board of Trustees v. United States, the Federal Circuit rejected a strict temporal limitation on when the Government’s license rights in patents stemming from federally funded research is...more
The Department of Commerce and the National Institute of Standards and Technology are requesting comments on a “draft guidance framework designed to help federal agencies evaluate when it may be appropriate to exercise...more
The Bayh–Dole Act, signed into law in 1980, is U.S. legislation directed to inventions arising from research funded by the Federal government. (See 35 U.S.C. § 200–212, and 37 C.F.R. §§ 401 and 404.) The Act encourages...more
Every year, the National Institutes of Health (NIH) spends billions of federal dollars on research and development of new drugs and therapies for treating and preventing serious illnesses....more
In a case involving medical methods invented by two Nobel laureates, the U.S. Court of Appeals for the Federal Circuit has ruled that sovereign immunity prevents a third researcher from pursuing his claim of co-inventorship...more
Two years ago today, the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits from their Utilization to the Convention on Biological Diversity (“Protocol”) entered into international...more